A genome-wide association study of late-onset Alzheimer’s disease in a Japanese population
暂无分享,去创建一个
Takashi Morihara | Masatoshi Takeda | Shigenobu Kanba | Akira Monji | Michiaki Kubo | Yutaka Kiyohara | Atsushi Takahashi | S. Kanba | M. Kubo | T. Ninomiya | A. Takahashi | M. Ikeda | M. Takeda | Y. Kiyohara | A. Monji | T. Kitazono | T. Morihara | H. Arai | N. Iwata | A. Hirano | E. Oshima | K. Ashikawa | M. Aoki | Y. Fuyuno | N. Shibata | Y. Okahisa | H. Akatsu | Takanari Kitazono | Heii Arai | T. Ohara | Nakao Iwata | Toshiharu Ninomiya | Hiroyasu Akatsu | Masashi Ikeda | Tomoyuki Ohara | Kouzin Kamino | Yuko Okahisa | Kyota Ashikawa | Nobuto Shibata | Atsushi Hirano | Masayuki Aoki | Yuta Fuyuno | Etsuko Oshima | K. Kamino | Masayuki Aoki | M. Kubo
[1] D. Pollen,et al. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease , 1995, Nature.
[2] Mark Daly,et al. Haploview: analysis and visualization of LD and haplotype maps , 2005, Bioinform..
[3] Nick C Fox,et al. Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease , 2013, Nature Genetics.
[4] Yusuke Nakamura,et al. Japanese population structure, based on SNP genotypes from 7003 individuals compared to other ethnic groups: effects on population-based association studies. , 2008, American journal of human genetics.
[5] P. Visscher,et al. A versatile gene-based test for genome-wide association studies. , 2010, American journal of human genetics.
[6] S. Kanba,et al. Trends in prevalence of Alzheimer’s disease and vascular dementia in a Japanese community: the Hisayama Study , 2010, Acta psychiatrica Scandinavica.
[7] Nick C Fox,et al. Common variants in ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer’s disease , 2011, Nature Genetics.
[8] Sudha Seshadri,et al. Genome-wide analysis of genetic loci associated with Alzheimer disease. , 2010, JAMA.
[9] P. Heutink,et al. CNTNAP2 is disrupted in a family with Gilles de la Tourette syndrome and obsessive compulsive disorder. , 2003, Genomics.
[10] J A Veltman,et al. CNTNAP2 gene dosage variation is associated with schizophrenia and epilepsy , 2008, Molecular Psychiatry.
[11] J. Rommens,et al. Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene , 1995, Nature.
[12] L. Fratiglioni,et al. Role of genes and environments for explaining Alzheimer disease. , 2006, Archives of general psychiatry.
[13] Thomas W. Mühleisen,et al. Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease , 2013, Nature Genetics.
[14] Robert C Green,et al. A comprehensive genetic association study of Alzheimer disease in African Americans. , 2011, Archives of neurology.
[15] Manuel A. R. Ferreira,et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. , 2007, American journal of human genetics.
[16] M. Folstein,et al. Clinical diagnosis of Alzheimer's disease , 1984, Neurology.
[17] D. Geschwind,et al. A functional genetic link between distinct developmental language disorders. , 2008, The New England journal of medicine.
[18] D. Stephan,et al. Recessive symptomatic focal epilepsy and mutant contactin-associated protein-like 2. , 2006, The New England journal of medicine.
[19] J. Haines,et al. Beyond proof of principle: new genes for Alzheimer's disease through collaboration , 2009, Lancet Neurology.
[20] J. Sebat,et al. Linkage, association, and gene-expression analyses identify CNTNAP2 as an autism-susceptibility gene. , 2008, American journal of human genetics.
[21] P. Bosco,et al. Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease , 2009, Nature Genetics.
[22] M. Pericak-Vance,et al. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease , 1991, Nature.
[23] Katarzyna Chawarska,et al. Molecular cytogenetic analysis and resequencing of contactin associated protein-like 2 in autism spectrum disorders. , 2008, American journal of human genetics.
[24] Peter Shrager,et al. Caspr2, a New Member of the Neurexin Superfamily, Is Localized at the Juxtaparanodes of Myelinated Axons and Associates with K+ Channels , 1999, Neuron.
[25] Anne Corbett,et al. Alzheimer's disease , 2011, The Lancet.
[26] Tanya M. Teslovich,et al. A common genetic variant in the neurexin superfamily member CNTNAP2 increases familial risk of autism. , 2008, American journal of human genetics.
[27] M. van Dijk,et al. Direct downregulation of CNTNAP2 by STOX1A is associated with Alzheimer's disease. , 2012, Journal of Alzheimer's disease : JAD.
[28] J. Haines,et al. SORL1 Is Genetically Associated with Late-Onset Alzheimer’s Disease in Japanese, Koreans and Caucasians , 2013, PloS one.
[29] D. G. Clark,et al. Common variants in MS4A4/MS4A6E, CD2uAP, CD33, and EPHA1 are associated with late-onset Alzheimer’s disease , 2011, Nature Genetics.
[30] K. Morgan,et al. Regulatory region single nucleotide polymorphisms of the apolipoprotein E gene and the rate of cognitive decline in Alzheimer's disease. , 2007, Human molecular genetics.
[31] A. Hofman,et al. Prevalence of dementia and major subtypes in Europe: A collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group. , 2000, Neurology.
[32] Shigenobu Kanba,et al. Association study of susceptibility genes for late-onset Alzheimer’s disease in the Japanese population , 2012, Psychiatric genetics.
[33] D. Reich,et al. Principal components analysis corrects for stratification in genome-wide association studies , 2006, Nature Genetics.
[34] Yusuke Nakamura,et al. A high-throughput SNP typing system for genome-wide association studies , 2001, Journal of Human Genetics.
[35] J. Haines,et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. , 1993, Science.
[36] D. Selkoe. Alzheimer's disease. , 2011, Cold Spring Harbor perspectives in biology.
[37] Yusuke Nakamura,et al. [BioBank Japan project]. , 2005, Nihon rinsho. Japanese journal of clinical medicine.